Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code AGR

16. Specific lobbying issues

Agricultural Education Policy

Biomass Programs (Non-Funding)
---Reauthorization of Biomass Crop Assistance Program
---Reauthorization of Biomass R&D Program
---H.R. 2: Agriculture and Nutrition Act
---S. 3042: Agriculture Improvement Act

EPA Regulations on Biotechnology
---H.R. 1029 Pesticide Registration Act
---Efficient Science-Based Reviews of Biotech Products

Foreign Agricultural Biotechnology Laws and Regulations
---Asynchronous Approvals
---China Biotechnology Regulations
---EU Ag-Biotech Policies and Regulations

Funding for Biomass Crop Assistance Program
---H.R. 2: Agriculture and Nutrition Act
---S. 3042: Agriculture Improvement Act
---H.R. 5961/S.2476: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019

Funding for the USDA
---H.R. 5961/S.2476: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019
---Foreign Agriculture Service Funding and Authority
------H.R. 5379: Growing American Food Exports Act

Genetically Engineered (GE) Animals
---Labeling
---Efficient Science-Based Review of Biotech Products
---FDA Proposed Guidance on Gene Editing
---H.R. 5961/S.2476: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019
------Amendment on GE Salmon Labeling
---The Animal Drug User Fee Reauthorization Act of 2018
------Amendment on GE Salmon Labeling

One Health
---S. 2615: Advancing Emergency Preparedness Through One Health Act

Potential Regulation of New Genetic Modification Technologies

Review and Labeling of Food Derived from Biotechnology
---Implementation of Disclosure Law

USDA/APHIS Agricultural Biotechnology Regulations
---Efficient Science-Based Review of Biotech Products
---Potential Revisions to Part 340 Regulations
---H.R. 2: Agriculture and Nutrition Act
---S. 3042: Agriculture Improvement Act

Review of the Coordinated Framework for Biotechnology Products

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), U.S. Trade Representative (USTR), White House Office, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ANI

16. Specific lobbying issues

Genetically Engineered (GE) Animals
---Labeling
---Efficient Science-Based Review of Biotech Products
---FDA Proposed Guidance on Gene Editing
---H.R. 5961/S.2476: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019
------Amendment on GE Salmon Labeling
---The Animal Drug User Fee Reauthorization Act of 2018
------Amendment on GE Salmon Labeling

One Health
---S. 2615: Advancing Emergency Preparedness Through One Health Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), White House Office, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Energy Basic Research Funding
---Advanced Research Projects Agency-Energy
---DOE Office of Science
---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019

Funding for Antimicrobial Resistance Programs
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Funding for Biofuels
---H.R. 2: Agriculture and Nutrition Act
---S.3042: Agriculture Improvement Act
------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title)
---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019

Funding for Biomass Crop Assistance Program
---H.R. 2: Agriculture and Nutrition Act
---S.3042: Agriculture Improvement Act
------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title)
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019

Funding for Biorefineries
---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program
---H.R. 2: Agriculture and Nutrition Act
---S.3042: Agriculture Improvement Act
------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title)
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019

Funding for FDA
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019

Funding for National Institutes of Health
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Funding for Renewable Chemicals/Bio-based Products
---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program
---Reauthorization of USDA Bio-Preferred Program
---H.R. 2: Agriculture and Nutrition Act
---S.3042: Agriculture Improvement Act
------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title)
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019
---EPA Safer Choice Program

Funding for the Centers for Disease Control and Prevention Vaccine Programs
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Funding for the USDA
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019
---Foreign Agriculture Service Funding and Authority
------H.R. 5379: Growing American Food Exports Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), Office of Management & Budget (OMB)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CHM

16. Specific lobbying issues

Funding for Renewable Chemicals/Bio-based Products
---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program
---Reauthorization of USDA Bio-Preferred Program
---H.R. 2: Agriculture and Nutrition Act
---S.3042: Agriculture Improvement Act
------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title)
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019

Renewable Chemicals/Bio-based Products (Non-Funding)
---Investment Tax Credit
---Production Tax Credit
---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program
---Reauthorization of USDA Bio-Preferred Program
---Nomenclature Usage
---H.R. 2: Agriculture and Nutrition Act
---S.3042: Agriculture Improvement Act
---H.R. 3149/S.1980: Renewable Chemicals Act of 2017
---H.R. 4118/S.2005: Master Limited Partnership Parity Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

Bayh-Dole Act/Tech Transfer
---March-In Rights

Foreign Drug Data Protection Laws

Intellectual Property International Enforcement
---Compulsory Licensing
---India
---Malaysia

Inter Partes Review
---Implementation of the America Invents Act of 2011
---H.R. 5340/S. 1390: STRONGER Patents Act
---H.R. 6264: Restoring America's Leadership Act
---Biomedical Innovation Protection Act of 2018 (Discussion Draft House/Senate)

North American Free Trade Agreement (NAFTA) Renegotiation
---IP Provisions

Patenting of Biological Inventions
---PTO Examination Guidelines
---Section 101 Modernization

Patent Reform
---H.R. 5340/S. 1390: STRONGER Patents Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR), White House Office, Patent & Trademark Office (PTO), State - Dept of (DOS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CSP

16. Specific lobbying issues

Drug Importation
---S.469: Affordable and Safe Prescription Drug Importation Act

Genetically Engineered (GE) Animals
---Labeling
---Efficient Science-Based Review of Biotech Products
---FDA Proposed Guidance on Gene Editing
---H.R. 5961/S.2476: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019
------Amendment on GE Salmon Labeling
---The Animal Drug User Fee Reauthorization Act of 2018
------Amendment on GE Salmon Labeling

Opioid Crisis
---NIH Research
---FDA Reforms
---Coverage and Reimbursement
---Transparency
---H.R. 5590: Opioid Addiction Action Plan Act
---H.R. 5002: Advancing Cutting Edge Research Act
---H.R. 5473: Better Pain Management Through Better Data Act
---H.R. 5806: 21st Century Tools for Pain Addiction Treatment
---H.R. 6: SUPPORT for Patients and Communities Act
---S.2665: Providing Clarity in Development of Pain Treatment
---S.2669: Advancing Innovation in Alternative Pain and Addiction Therapies Act
---S.2680: Opioid Crisis Response Act
---S.2769: HEAL Act

Review and Labeling of Food Derived from Biotechnology
---Implementation of Disclosure Law

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), White House Office, Natl Economic Council (NEC), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ENG

16. Specific lobbying issues

Biofuels (Non-Funding)
---Accelerated Depreciation of Biofuels Facilities Extension
---Production Tax Credit Extension
---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program
---H.R. 2: Agriculture and Nutrition Act
---S. 3042: Agriculture Improvement Act
---H.R. 4118/S. 2005: Master Limited Partnership Parity Act

Biomass Programs (Non-Funding)
---Reauthorization of Biomass Crop Assistance Program
---Reauthorization of Biomass R&D Program
---H.R. 2: Agriculture and Nutrition Act
---S. 3042: Agriculture Improvement Act

Biorefineries (non-funding)
---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program
---H.R. 2: Agriculture and Nutrition Act
---S. 3042: Agriculture Improvement Act

Energy Basic Research Funding
---DOE Office of Science
---Advanced Research Projects Agency-Energy
---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019

Funding for Biofuels
---H.R. 2: Agriculture and Nutrition Act
---S. 3042: Agriculture Improvement Act
------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title)
---H.R. 5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019

Funding for Biomass Crop Assistance Program
---H.R. 2: Agriculture and Nutrition Act
---S. 3042: Agriculture Improvement Act
------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title)
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019

Funding for Biorefineries
---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program
---H.R. 2: Agriculture and Nutrition Act
---S. 3042: Agriculture Improvement Act
------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title)
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019

Renewable Fuel Standard (RFS)
---Changes to the Point of Obligation under the RFS
---RFS Reform
---H.R. 1311/S.517: Consumer and Fuel Retailer Choice Act

Review of the Federal Coordinated Framework for Biotechnology Products

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA), Natl Economic Council (NEC), Office of Management & Budget (OMB)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code FOO

16. Specific lobbying issues

Genetically Engineered (GE) Animals
---Labeling
---Efficient Science-Based Review of Biotech Products
---FDA Proposed Guidance on Gene Editing
--------Amendment on GE Salmon Labeling
---The Animal Drug User Fee Reauthorization Act of 2018
------Amendment on GE Salmon Labeling

Review and Labeling of Food Derived from Biotechnology
---Implementation of Disclosure Law

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), White House Office, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code FUE

16. Specific lobbying issues

Biofuels (Non-Funding)
---Accelerated Depreciation of Biofuels Facilities Extension
---Production Tax Credit Extension
---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program
---H.R. 2: Agriculture and Nutrition Act
---S. 3042: Agriculture Improvement Act
---H.R. 4118/S. 2005: Master Limited Partnership Parity Act

Biomass Programs (Non-Funding)
---Reauthorization of Biomass Crop Assistance Program
---Reauthorization of Biomass R&D Program
---H.R. 2: Agriculture and Nutrition Act
---S. 3042: Agriculture Improvement Act

Biorefineries (non-funding)
---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program
---H.R. 2: Agriculture and Nutrition Act
---S. 3042: Agriculture Improvement Act

Energy Basic Research Funding
---DOE Office of Science
---Advanced Research Projects Agency-Energy
---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019

Funding for Biofuels
---H.R. 2: Agriculture and Nutrition Act
---S. 3042: Agriculture Improvement Act
------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title)
---H.R. 5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019

Funding for Biomass Crop Assistance Program
---H.R. 2: Agriculture and Nutrition Act
---S. 3042: Agriculture Improvement Act
------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title)
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019

Funding for Biorefineries
---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program
---H.R. 2: Agriculture and Nutrition Act
---S. 3042: Agriculture Improvement Act
------Klobuchar Amendment #1 to Agriculture Improvement Act (Mandatory Funding of Energy Title)
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019

Renewable Fuel Standard (RFS)
---Changes to the Point of Obligation under the RFS
---RFS Reform
---H.R. 1311/S.517: Consumer and Fuel Retailer Choice Act

Review of the Federal Coordinated Framework for Biotechnology Products

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA), Natl Economic Council (NEC), Office of Management & Budget (OMB)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

340B Drug Discount Program
---Program Implementation & Oversight
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019
---H.R. 4710: 340B Pause Act
---H.R. 5598: 340B Optimization Act
---S. 2453: Ensuring the Value of the 340B Program Act

Access to Medicines/World Health Organization

Antibiotic & Diagnostic Tax Credit
---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation

Biodefense Research, Development and Procurement Issues (Non-funding)
---Tropical Disease Priority Review Voucher (PRV) Program
---Implementation of Medical Countermeasures Innovation Act
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019
---Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Act of 2017 (Reps. Brooks/Eshoo Discussion Draft)
---S.2852: Pandemic and All-Hazards Preparedness and Innovation Act (PAHPAIA)

Biosimilars
---Access to Samples for Testing
---Interchangeability and Pharmacy Substitution
---S. 974/H.R. 2212: CREATES Act of 2017

Drug Evaluation and Review
---Compassionate Use/Expanded Access
---Expedited Pathways
---FDA Proposed Rule on Changes to Drug Labeling
---Innovation Incentives
---Patient-Focused Drug Development
---S.204 / H.R. 878: Right to Try Act of 2017
---Prescription Drug User Fee Act (PDUFA) VI Implementation
---FDA Management & Financial Accountability
---FDA Hiring Flexibility
---Priority Review Voucher Program
---Regulatory Reform & Modernization
---Use of Real World Evidence

Drug Importation
---S.469: Affordable and Safe Prescription Drug Importation Act

Drug Manufacturing, Quality & Distribution
---Pharmacy Compounding & Oversight
---Drug Shortages
---Supply Chain Integrity and Traceability
---Counterfeiting

Drug Pricing
---HHS Blueprint to lower drug prices and reduce out of pocket costs
---S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017
---S. 1369 / H.R. 2974: Stop Price Gouging Act
---S. 637: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act
---S. 771: Improving Access to Affordable Prescription Drugs

Drug Product Communications

Foreign Drug Data Protection Laws

Funding for Antimicrobial Resistance Programs
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
---H.R. 3219: Department of Defense Appropriations Act for FY 2018
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Funding for FDA
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019

Funding for National Institutes of Health
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Funding for the Centers for Disease Control and Prevention Vaccine Programs
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Generic Drug Entry
---Access to Samples for Testing
---Generic Drug Application Review Reforms
---Incentives for Generic Entry
---S. 974/H.R. 2212: CREATES Act of 2017

Medicaid
---Drug Benefit Design
---Pricing and Rebates
---Average Manufacturer Price Calculations

North American Free Trade Agreement (NAFTA) Renegotiation
---Pricing and Reimbursement Provisions
---IP Provisions

Opioid Crisis
---NIH Research
---FDA Reforms
---Coverage and Reimbursement
---Transparency
---H.R. 5590: Opioid Addiction Action Plan Act
---H.R. 5002: Advancing Cutting Edge Research Act
---H.R. 5473: Better Pain Management Through Better Data Act
---H.R. 5806: 21st Century Tools for Pain Addiction Treatment
---H.R. 6: SUPPORT for Patients and Communities Act
---S.2665: Providing Clarity in Development of Pain Treatment
---S.2669: Advancing Innovation in Alternative Pain and Addiction Therapies Act
---S.2680: Opioid Crisis Response Act
---S.2769: HEAL Act

Orphan Drug Issues
---Tax Credit

Reimbursement for Innovative Products
---HHS Blueprint to lower drug prices and reduce out of pocket costs
---Medicare Part B Physician-Administered Products
---Medicare Part D Prescription Drug Program
---Third Party Support of Patient Premiums and Cost-Sharing Obligations
---Value-based Contracting and Communications
---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017
---S. 771: Improving Access to Affordable Prescription Drugs
---H.R. 6142/S. 2042: Reducing Drug Waste Act

Trade and Foreign Drug Price Controls

UN High Level Commission on Access to Medicines
---IP Proposals

Vaccines and Infectious Diseases
---Vaccine and Anti-Microbial Resistance Product Development and Incentives
---Vaccine Injury Compensation Program
---Vaccine Safety
---Adult Immunization Education
---H.R. 4993: Vaccine Access Improvement Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Natl Security Council (NSC), White House Office, U.S. Trade Representative (USTR), Natl Economic Council (NEC), Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Office of Science & Technology Policy (OSTP)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HOM

16. Specific lobbying issues

Biodefense Research, Development and Procurement Issues (Non-funding)
---Tropical Disease Priority Review Voucher (PRV) Program
---Implementation of Medical Countermeasures Innovation Act
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019
---Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Act of 2017 (Reps. Brooks/Eshoo Discussion Draft)
---S.2852: Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAIA)

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MED

16. Specific lobbying issues

Biodefense Research, Development and Procurement Issues (Non-funding)
---Tropical Disease Priority Review Voucher (PRV) Program
---Implementation of Medical Countermeasures Innovation Act
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019
---Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Act of 2017 (Reps. Brooks/Eshoo Discussion Draft)
---S.2852: Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAIA)

Funding for Antimicrobial Resistance Programs
---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Funding for National Institutes of Health
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Funding for the Centers for Disease Control and Prevention Vaccine Programs
---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Medicaid
---Drug Benefit Design
---Pricing and Rebates
---Average Manufacturer Price Calculation

Reimbursement for Innovative Products
---HHS Blueprint to lower drug prices and reduce out of pocket costs
---Medicare Part B Physician-Administered Products
---Medicare Part D Prescription Drug Program
---Third Party Support of Patient Premiums and Cost-Sharing Obligations
---Value-based Contracting and Communications
---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017
---S. 771: Improving Access to Affordable Prescription Drugs
---H.R. 6142/S. 2042: Reducing Drug Waste Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code SMB

16. Specific lobbying issues

Proxy Advisory Services
---Impact of Policies on Small Public Companies
---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017

Sarbanes Oxley Section 404 (b)
---H.R. 1645/S. 2126: Fostering Innovation Act
---Small Issuer Exemption
---Accelerated Filer Definition

Short Selling Transparency

XBRL Exemption for Small Public Companies
---H.R. 5054: Small Company Disclosure Simplification Act
---H.R. 10: Financial Choice Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Securities & Exchange Commission (SEC)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

Biofuels (Non-Funding)
---Accelerated Depreciation of Biofuels Facilities Extension
---Production Tax Credit Extension
---H.R. 4118/S. 2005: Master Limited Partnership Parity Act

Capital Formation Investment Incentives
---Reform of Net Operating Loss Rules

Orphan Drug Issues
---Tax Credit

Renewable Chemicals/Bio-based Products (Non-Funding)
---Investment Tax Credit
---Production Tax Credit
---HR 3149/S. 1980: Renewable Chemicals Act of 2017
---H.R. 4118/S. 2005: Master Limited Partnership Parity Act

Qualified Small Business Stock (QSBS)

Research & Development Tax Credit Reforms
---Refundable R&D Credit

Vaccines and Infectious Diseases
---Vaccine Injury Compensation Program
---H.R. 4993: Vaccine Access Improvement Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TRD

16. Specific lobbying issues

Drug Importation
---S.469: Affordable and Safe Prescription Drug Importation Act

Foreign Agricultural Biotechnology Laws and Regulations
---Asynchronous Approvals
---China Biotechnology Regulations
---EU Ag-Biotech Policies and Regulations

Foreign Drug Data Protection Laws

Funding for the USDA
---Foreign Agriculture Service Funding and Authority
------H.R. 5379: Growing American Food Exports Act

Intellectual Property International Enforcement
---Compulsory Licensing
---India
---Malaysia

North American Free Trade Agreement (NAFTA) Renegotiation
---IP Provisions
---Pricing and Reimbursement Provisions

Trade and Foreign Drug Price Controls

UN High Level Commission on Access to Medicines
---IP Proposals

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), White House Office, U.S. Trade Representative (USTR), Council of Economic Advisers (CEA), State - Dept of (DOS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization